As an independent consultant, I advise on the intersection of
biotechnology, AI, and
precision medicine. At
Origen Biotech Corp.'s
Genetics division, I specialize in integrating genomics and epigenetics to drive precision medicine through advanced whole genome sequencing (WGS) analysis. Our solution combines deep bioinformatics expertise with domain-specific knowledge across different HCLS domains, plus strategic partnerships for specialized biomarker measurement. I deploy machine learning models that generate predictive outputs for each scientific field, continuously validated by our multidisciplinary scientific committee and updated* with emerging evidence from non-coding genome regions, as well as from spatially resolved transcriptomic technologies that integrate molecular readouts with tissue architecture and imaging, enabling the discovery of region-specific biomarker patterns that bulk approaches typically miss. Through our alliance, amongst others, with a leading cloud
Company (where I'm the Product Owner of the HCLS line) we are developing intelligent, holistic solutions—including a proprietary precision medicine
platform that delivers personalized recommendations based on individual genetic profiles, that identifies multiple aging subtypes to enable personalized longevity interventions targeting specific frailty phenotypes—. Our intelligent *
crawler continuously updates our genetic “
Knowlake” with certified, peer-reviewed research, ensuring clients have instant access to the latest scientific insights on previously unexplored genomic territories.